Interleukins and their antagonists but not TNF and its receptors are released in post-ERP pancreatitis

European Journal of Gastroenterology and Hepatology

Volumn 10, Issue 7, 1998, Pages 611-617

  Messmann, Helmut ^a   Vogt, Wolfgang ^a   Falk, Werner ^a   Vogl, Daniela ^a   Zirngibl, Hubert ^a   Leser, Hans Georg ^a   Schölmerich, Jürgen ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Anti cytokines; Cytokines; Post ERP pancreatitis

Indexed keywords

AMYLASE; C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ABDOMINAL PAIN; ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ARTICLE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; NAUSEA; PERITONITIS; PRIORITY JOURNAL; SYMPTOM; VOMITING;

EID: 0031824676     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199807000-00016     Document Type: Article

References (24)

1. Leser H-G, Gross V, Scheibenbogen C, Heinisch A, Salm R, Lausen M, et al. Elevation of interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 1991; 101:782-785.
2. Viedma JA, Pérez-Mateo M, Dominguez JE, Carballo F. Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. Gut 1992; 33:1264-1267.
3. Heath DI, Cruickshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993; 34:41-45.
4. Groß V, Leser HG, Andreesen R, Ceska M, Liehl E, Lausen M, et al. Interleukin-8 (IL-8) and neutrophil activation in acute pancreatitis. Eur J Clin Invest 1991; 22:200-203.
5. 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein. Dig Dis Sci 1995; 40:2341-2348.
6. Exley AR, Leese T, Holliday MP, Swann RA, Cohen J. Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe pancreatitis. Gut 1992; 33:1126-1128.
7. Takács T, Farkas G, Czakó L. Jármy K, Mándi Y, Lonovics J. Time-course in serum cytokine levels in two experimental acute pancreatitis models in rats. Res Exp Med 1996; 196:153-161.
8. Messmann H, Vogt W, Holstege A, Lock G, Heinisch A, von Fürstenberg A, et al. Post-ERP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis. Gut 1997; 40: 80-85.
9. Tracey KJ, Lowry SF. The role of cytokine mediators in septic shock. Adv Surg 1990; 23:21-56.
10. Baigrie RJ, Lamont PM, Dallman M, Morris PJ. The release of interleukin-1β (IL-1) precedes that of interleukin 6 (IL-6) in patients undergoing major surgery. Lymphokine Cytokine Res 1991; 10:253-256.
11. Schröder J, Stüber F, Gallati H, Schade FU, Kremer B. Pattern of soluble TNF receptors I and II in sepsis. Infection 1995; 23:143-148.
12. Schölmerich J. Interleukins in acute pancreatitis. Scand J Gastroenterol 1996; 31 (Suppl. 219):37-42.
13. Tanaka N, Murata A, Uda K, Toda H, Kato T, Hayashida H, et al., Interleukin-1 receptor antagonist modifies the changes in vital organs induced by acute necrotizing pancreatitis in a rat experimental model. Crit Care Med 1995; 23:901-908.
14. Norman JG, Franz MG, Fink GS, Messina J, Fabri PJ, Gower WR, Carey LC. Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann Surg 1995; 221:625-634.
15. Norman J, Franz MG, Messina J, Riker A, Fabri PJ, Rosemurgy AS, Gower WR. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 1994; 117:648-655.
16. De Beaux AC, Goldie AS, Ross JA, Carter DC, Fearon KHC. Serum concentrations of inflammatory mediators related to organ failure with acute pancreatitis. Br J Surg 1996; 83:349-353.
17. Goldie AS, Fearon KC, Ross JA, Barclay R, Jackson RE, Grant IS, et al. Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. JAMA 1995; 274:172-177.
18. Pezzilli R, Billi P, Gullo L, Beltrandi E, Maldini M, Mancini R, et al. Behavior of serum soluble interleukin-2 receptor, soluble CD8 and soluble CD4 in the early phases of acute pancreatitis. Digestion 1994; 44:268-273.
19. Curley P, Nestor M, Collins K, Saporoschetz I, Mendez M, Mannick JA, Rodrick ML. Decreased interleukin-2 production in murine acute pancreatitis: potential for immunomodulation. Gastroenterology 1996; 110:583-588.
20. Pezzilli R, Billi P, Beltrandi E, Maldini M, Mancini M, Morsilli Labate AM. Miglioli M. Circulating lymphocyte subsets in human acute pancreatitis. Pancreas 1995; 11:95-100.
21. LaFerla G, Gordon S, Archibals M, Murray WR. Hyperamylasaemia and acute pancreatitis following endoscopic retrograde cholangiography. Pancreas 1985; 1:160-163.
22. Johnson GK, Geenen JE, Hohanson JF, Sherman S, Hogan WJ, Cass O and other members of the Midwest Pancreaticobiliary Study Group. Evaluation of post-ERP pancreatitis: potential causes noted during controlled study of differing contrast media. Gastrointest Endosc 1997; 46:217-222.
23. McKay CJ, Gallagher G, Brooks B, Imrie CW, Baxter JN. Increased monocyte cytokine production in association with systemic complications in acute pancreatitis. Br J Surg 1996; 83:919-923.
24. Mosman TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7:145-173.